Status:
COMPLETED
Prolonged Exposure Therapy for PTSD and Opioid Use Disorder
Lead Sponsor:
University of Vermont
Collaborating Sponsors:
National Institute of General Medical Sciences (NIGMS)
Conditions:
Post Traumatic Stress Disorder
Opioid-use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Among patients with opioid use disorder (OUD), 90% report lifetime trauma exposure and 33% meet criteria for posttraumatic stress disorder (PTSD). The co-occurrence of OUD and PTSD is associated with ...
Detailed Description
Among patients with opioid use disorder (OUD), 90% report lifetime trauma exposure and 33% meet criteria for posttraumatic stress disorder (PTSD). The co-occurrence of OUD and PTSD is associated with ...
Eligibility Criteria
Inclusion
- \>18 years old
- currently maintained on a stable methadone or buprenorphine dose for \>1 month prior to the study
- endorse \>1 lifetime traumatic event
- meet current DSM-V posttraumatic stress disorder criteria
Exclusion
- Presence of an acute psychotic disorder, bipolar disorder with an active manic episode
- imminent risk for suicide
- a medical condition that may interfere with consent or participation
- illiteracy in English
Key Trial Info
Start Date :
April 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04104022
Start Date
April 6 2021
End Date
July 31 2023
Last Update
January 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Vemont
Burlington, Vermont, United States, 05401